EUVIMED · CrossrefZeitschrift
Trials in Vaccinology
ISSN 1879-4378 · Elsevier BV
Neueste Artikel
Chimeric avian paramyxovirus-based vector immunization against highly pathogenic avian influenza followed by conventional Newcastle disease vaccination eliminates lack of protection from virulent ND virus
Publisher's Note – Launching Trials in Vaccinology
Welcome Editorial to Trials in Vaccinology
Rotavirus serotype distribution in northern Brazil trends over a 27 year period pre and post national vaccine introduction
Clinical development, registration, and introduction of human rotavirus vaccine: The Latin American experience
WITHDRAWN: Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic scherichia coli
Optimizing the efficiency of therapeutic HIV vaccine trials: A case for CTN 173
A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
Rotavirus gastroenteritis in Latin America: A hospital-based study in children under 3 years of age
Trivalent inactivated subunit influenza vaccine Influvac®: 30-year experience of safety and immunogenicity
Efficacy of vaccination of 3-week-old piglets with Circovac® against porcine circovirus diseases (PCVD)
Clinical evaluation to confirm the manufacturing consistency of three lots of an adjuvanted glycoprotein D genital herpes vaccine in healthy seronegative pre-teen and adolescent girls: A phase III multi-center double-blind randomized trial
Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil – A combination of strategies to increase immunization coverage and early reduction of genital warts
Hospital-based surveillance study of rotavirus gastroenteritis in children under 5 years of age in Lebanon
Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom’s macroglobulinemia, and monoclonal gammopathy of undetermined significance
A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle
Effectiveness, tolerability and patient satisfaction of paediatric live-attenuated influenza immunization (LAIV) in routine-care in Germany: A case-control-study
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in people aged 65 years and over in the North East of England, April 2006–July 2012
A neonatal oral Mycobacterium tuberculosis-SIV prime/intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques
Analysis of recombinant, multivalent dengue virus containing envelope (E) proteins from serotypes-1, -3 and -4 and expressed in baculovirus
Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice
Protective immune mechanisms against pre-erythrocytic forms of Plasmodium berghei depend on the target antigen
The feasibility of rabies virus-vectored immunocontraception in a mouse model
Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines
HIV-1 Gag-specific exosome-targeted T cell-based vaccine stimulates effector CTL responses leading to therapeutic and long-term immunity against Gag/HLA-A2-expressing B16 melanoma in transgenic HLA-A2 mice
Co-administration of an adjuvanted FeLV vaccine together with a multivalent feline vaccine to cats is protective against virulent challenge with feline leukaemia virus, calicivirus, herpes virus and panleukopenia virus
Randomized trial: The effect of oral polio vaccine at birth on polio antibody titers at 6 weeks and 6 months of age
Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection
Highly immunogenic prime–boost DNA vaccination protects chickens against challenge with homologous and heterologous H5N1 virus
Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats
EUVIMED